引用本文:叶丽华.神经节苷脂钠治疗新生儿胆红素脑病临床疗效观察[J].中国临床新医学,2012,5(3):227-229.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1257次   下载 1145 本文二维码信息
码上扫一扫!
分享到: 微信 更多
神经节苷脂钠治疗新生儿胆红素脑病临床疗效观察
叶丽华
535000 广西,钦州市第二人民医院儿科
摘要:
[摘要] 目的 观察应用神经节苷脂钠治疗新生儿胆红素脑病的疗效。方法 选择新生儿胆红素脑病42例随机分为治疗组(22例)和对照组(20例)。两组均给予常规治疗,治疗组在常规治疗基础上急性期给予神经节苷脂钠(GM1)治疗,剂量20 mg/d,共治疗7 d(一个疗程)。观察两组治疗后的效果并对神经行为进行评分。结果 治疗组的疗效明显优于对照组(P<0.05),治疗后神经行为评分高于对照组(P<0.01)。结论 神经节苷脂钠治疗新生儿胆红素脑病可提高干预效果,减少后遗症的发生。
关键词:  新生儿胆红素脑病  神经节苷脂钠  疗效
DOI:10.3969/j.issn.1674-3806.2012.03.14
分类号:R 722
基金项目:
Clinical observation of ganglioside in the treatment of neonatal bilirubin encephalopathy
YE Li-hua
Department of Newborns, the Qinzhou Second People′s Hospital, Guangxi 535000, China
Abstract:
[Abstract] Objective To observe the therapeutic effect of ganglioside in the treatment of neonatal bilirubin encephalopathy.Methods Forty-two cases of neonatal bilirubin encephalopathy were randomly divided into the treatment group (22 cases) and control group (20 cases).The control group was treated with conventional treatment.On the conventional treatment,the treatment group was treated with ganglioside GM1 in the acute period, dose of 20 mg/d, 7 days for a course.The behavioral neurological assessment (NBNA) and therapeutic effect was determined during hospitalization.Results The therapeutic effect in the treatment group was significantly better than that in the control group(P<0.05),and NBNA scores in the treatment was higher than that in the control group(P<0.01).Conclusion Ganglioside which treats the neonatal bilirubin encephalopathy can increase the effect of intervention.
Key words:  Neonatal bilirubin encephalopathy  Ganglioside  Therapeutic effect